| GBP millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | (0.0) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 1.0 | 0.8 | 0.7 | 1.0 | 0.8 | 1.4 | +74.9% | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | −100.0% | |
| Operating expenses | 1.0 | 0.8 | 0.9 | 1.4 | 0.9 | 1.4 | +55.2% | |
| Operating income | (1.0) | (0.8) | (1.0) | (1.2) | (0.9) | (1.4) | −55.1% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | +3.3% | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other income / expense | (0.0) | 0.1 | (0.0) | (0.2) | (0.0) | (0.2) | −256.4% | |
| Pre-tax income | (1.1) | (0.7) | (1.1) | (1.4) | (1.0) | (1.6) | −64.5% | |
| Income tax | 0.0 | 0.0 | (0.0) | 0.0 | 0.0 | 0.0 | — | |
| Net income | (1.1) | (0.7) | (1.1) | (1.4) | (1.0) | (1.6) | −64.5% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (0.02) | (0.01) | (0.01) | (0.01) | (0.00) | (0.01) | −20.0% | |
| EPS, diluted (per share) | (0.02) | (0.01) | (0.01) | (0.01) | (0.00) | (0.01) | −20.0% | |
| EBITDA | (1.0) | (0.6) | (0.7) | (1.4) | (0.9) | (1.5) | −67.6% | |
| Depreciation & amortization | 0.0 | 0.0 | 0.7 | 1.4 | 0.8 | 0.0 | −100.0% | |
| Weighted average shares (shares) | 60,707,758 | 114,070,000 | 160,790,000 | 200,042,000 | 216,036,000 | 295,608,560 | +36.8% | |
| Weighted average diluted shares (shares) | 60,707,758 | 114,070,000 | 160,790,000 | 200,041,000 | 216,036,000 | 295,608,560 | +36.8% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
